COVID CODS Trial
COVID OLFACTORY DYSFUNCTION STUDY (COVID CODS TRIAL)
The purpose of the study is to define the ability to correctly identify COVID positive patients based on the loss of smell as a presenting symptom to the diagnosis of COVID. Another goal of the study is to define the percentage of COVID positive patients who experience recovery of smell and determine what baseline and clinical factors, if any, can predict recovery.
Dr. Jay Piccirillo
1. Participants must have a positive COVID test result
2. Participants must report anosmia (loss of smell) as a presenting symptom
For more information about this study, contact Volunteer for Health at: